CMS121 powder manufacturer CAS No.: 1353224-53-9 98.0% purity min. for supplement ingredients
Product Parameters
|
Product name |
CMS121 |
|
Other name |
CMS-121; 1,2-Benzenediol,4-[4-(cyclopentyloxy)-2-quinolinyl]-; 4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol(CMS121); ACC,AcetylCoenzymeACarboxylase,disease,neuroprotective,inhibit,anti-inflammatory,mitochondrial,Alzheimer's,antioxidative,acetylation,Inhibitor,H3K9,Acetyl-CoACarboxylase,CMS121,dementia,ACC1,CMS-121 |
|
CAS No. |
1353224-53-9 |
|
Molecular formula |
C20H19NO3 |
|
Molecular weight |
321.37 |
|
Purity |
98.0% |
|
Appearance |
Light yellow powder |
|
Application |
Dietary Supplement Raw Material |
Product introduction
4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol is a compound also called CMS121. The compound's structural complexity suggests it may have unique properties and potential uses. To understand its importance, it helps to identify the functional groups present and analyze their potential impact. The presence of the quinoline ring suggests that the compound may be biologically active. Quinoline-derived molecules are known for their diverse biological properties, including antibacterial and anti-inflammatory activities. Attachment of the cyclopentyloxy group may contribute to the solubility of the compound or enhance its biological activity through steric effects. In studies on HT22 cells, CMS-121 has demonstrated significant neuroprotective effects, effectively protecting these cells from ischemia and oxidative damage. Furthermore, CMS-121 has significant anti-inflammatory properties, indicating its ability to modulate inflammatory responses. By doing so, CMS-121 has the potential to reduce inflammation in various tissues and organs. CMS-121 has strong pharmacological activity as an inhibitor of acetyl-CoA carboxylase 1 (ACC1). Its potent inhibitory effect on ACC1 makes it a promising compound.
Feature
(1) High purity: CMS-121 can obtain high-purity products through refined production processes. High purity means better bioavailability and fewer adverse reactions.
(2) Safety: High safety, few adverse reactions.
(3) Stability: CMS-121 has good stability and can maintain its activity and effect under different environments and storage conditions.
Applications
CMS-121 is a quinolone derivative and orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor with promising pharmacological properties. Extensive research has been conducted to investigate the potential benefits of CMS-121 in various areas, including neuroprotection, anti-inflammatory effects, antioxidant activity, and its impact on markers associated with healthy aging.
